Covariate-adjusted win statistics in randomized clinical trials with ordinal outcomes

๐Ÿ“… 2025-08-27
๐Ÿ“ˆ Citations: 0
โœจ Influential: 0
๐Ÿ“„ PDF
๐Ÿค– AI Summary
In randomized trials with ordinal outcomes (e.g., disease progression grades), conventional ordinal regression suffers from bias when the proportional odds assumption fails or due to non-collapsibility. To address this, we propose a pairwise comparison framework based on the win ratio and win difference, and develop covariate-adjusted, propensity scoreโ€“weighted U-statistic estimators. We innovatively integrate inverse probability weighting (IPW) with overlap weighting (OW) to construct an enhanced doubly robust estimator that improves efficiency while preserving double robustness. We derive its asymptotic normality and consistent variance estimation, and implement it in the R package *winPSW*. Simulation studies and reanalysis of the ORCHID trial demonstrate that our method substantially outperforms unadjusted estimators, and the enhanced estimator further reduces mean squared error. The approach provides a generalizable, efficient, and robust tool for average treatment effect inference on ordinal outcomes.

Technology Category

Application Category

๐Ÿ“ Abstract
Ordinal outcomes are common in clinical settings where they often represent increasing levels of disease progression or different levels of functional impairment. Such outcomes can characterize differences in meaningful patient health states that are directly relevant to clinical researchers and frequently represent composite outcomes that include absorbing states such as death. To compare different intervention strategies in clinical trials, the direct use of ordinal logistic regression models may not be ideal for analyzing ranked outcomes due to non-collapsibility, lack of estimation and clarity, or failure of the common underlying proportional odds assumption. In this article, we focus on representing the average treatment effect for ordinal outcomes via intrinsic pairwise outcome comparisons captured through win estimates, such as the win ratio and win difference. We first develop propensity score weighting estimators, including both inverse probability weighting (IPW) and overlap weighting (OW), tailored to estimating win parameters. Furthermore, we develop augmented weighting estimators that leverage an additional ordinal outcome regression to potentially improve efficiency over weighting alone. Leveraging the theory of U-statistics, we establish the asymptotic theory for all estimators, and derive closed-form variance estimators to support statistical inference. Through extensive simulations we demonstrate the enhanced efficiency of the weighted estimators over the unadjusted estimator, with the augmented weighting estimators showing a further improvement in efficiency except for extreme cases. Finally, we illustrate our proposed methods with the ORCHID trial, and implement our covariate adjustment methods in an R package winPSW to facilitate the practical implementation.
Problem

Research questions and friction points this paper is trying to address.

Addresses non-collapsibility issues in ordinal outcome analysis
Develops covariate-adjusted win statistics for clinical trials
Improves efficiency in estimating treatment effects for ordinal outcomes
Innovation

Methods, ideas, or system contributions that make the work stand out.

Propensity score weighting estimators for win parameters
Augmented weighting estimators with ordinal outcome regression
Closed-form variance estimators using U-statistics theory
๐Ÿ”Ž Similar Papers
No similar papers found.
Zhiqiang Cao
Zhiqiang Cao
Oak Ridge National Lab
Flexible ElectronicsNeutron ScatteringIsotope Effect
S
Scott Zuo
Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Illinois, U.S.A
M
Mary Ryan Baumann
Department of Biostatistics and Medical Informatics, University of Wisconsin - Madison, Wisconsin, U.S.A; Department of Population Health Sciences, University of Wisconsin - Madison, Wisconsin, U.S.A
K
Kendra Plourde
Department of Biostatistics, Yale University School of Public Health, Connecticut, U.S.A; Yale Center for Analytical Sciences, Yale University School of Public Health, Connecticut, U.S.A
P
Patrick Heagerty
Department of Biostatistics, University of Washington, Washington, U.S.A; Clinical Learning, Evidence, and Research (CLEAR) Center, University of Washington, Washington, U.S.A
G
Guangyu Tong
Department of Biostatistics, Yale University School of Public Health, Connecticut, U.S.A; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, Connecticut, U.S.A; Cardiovascular Medicine Analytics Center, Yale School of Medicine, Connecticut, U.S.A; Center for Methods in Implementation and Prevention Science, Yale School of Public Health, Connecticut, U.S.A
F
Fan Li
Department of Biostatistics, Yale University School of Public Health, Connecticut, U.S.A; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, Connecticut, U.S.A; Cardiovascular Medicine Analytics Center, Yale School of Medicine, Connecticut, U.S.A; Center for Methods in Implementation and Prevention Science, Yale School of Public Health, Connecticut, U.S.A